A new drug called AF-130 has been developed that offers “two-for-one” treatment of heart failure and sleep apnea by targeting the nervous activity that drives both. newatlas.com Submitted by chrisdh79 t3_127m0gx on March 31, 2023 at 1:46 PM in science 44 comments 702
Xerenopd t1_jeh3ly3 wrote on March 31, 2023 at 11:44 PM I thought sleep apnea was just due to mouth breathing? Permalink −6−
Viewing a single comment thread. View all comments